Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Clinical trials sponsored by Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd, explained in plain language.

Now part of Chongqing Zhifei Biological Products Co., Ltd. 300122 SZSE

A biopharmaceutical subsidiary of Chongqing Zhifei, focusing on vaccines and biologics.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Not yet finished but already full! 1 Completed 1

New vaccine targets 26 pneumococcal strains in early trial

Vaccine Completed

This completed Phase I/II trial tested a new 26-valent pneumococcal conjugate vaccine in 450 people aged 2 months and older. The goal was to check safety and how well the vaccine triggers an immune response compared to existing vaccines. Researchers monitored side effects and ant…

Phase 1/2 • Sponsor: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd • Aim: Vaccine

Last updated Jun 27, 2026 12:01 UTC

Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

New vaccine targets 26 pneumococcal strains in early trial